Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
Drug Development and Industrial Pharmacy
|
April 23, 2013
Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers
Farhaan Hafeez, Xiaoying Hui, Marc Selner, et al.
European Journal of Dermatology : EJD
|
August 25, 2010
Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story"
Ana Gimenez-Arnau, Marcus Maurer, Jesús De La Cuadra, et al.
Molecular Pharmaceutics
|
October 4, 2024
Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes
Mohsen Ghaferi, Seyed Ebrahim Alavi, Khanh Phan, et al.
Journal of Applied Toxicology : JAT
|
September 29, 2016
Effects of soap-water wash on human epidermal penetration
Hanjiang Zhu, Eui-Chang Jung, Christina Phuong, et al.
Journal of Applied Toxicology : JAT
|
November 17, 2015
Effects of soap-water wash on human epidermal penetration
Hanjiang Zhu, Eui-Chang Jung, Christina Phuong, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews
|
July 26, 2021
Efficacy of water-based skin decontamination of occupational chemicals using <i>in vitro</i> human skin models: a systematic review
Chavy Chiang, Nadia Kashetsky, Aileen Feschuk, et al.
Cutaneous and Ocular Toxicology
|
July 27, 2011
Allergic contact dermatitis: effect of age
Hongbo Zhai, Susan R Meier-Davis, Brenda Cayme, et al.
Cutaneous and Ocular Toxicology
|
October 5, 2011
Irritant contact dermatitis: effect of age
Hongbo Zhai, Susan R Meier-Davis, Brenda Cayme, et al.
Cutaneous and Ocular Toxicology
|
March 29, 2013
Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?
Giovanni Brandi, Michela Venturi, Emi Dika, et al.
Cutaneous and Ocular Toxicology
|
May 4, 2013
Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
Annalisa Patrizi, Michela Venturi, Emi Dika, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
Drug Development and Industrial Pharmacy
|
April 23, 2013
Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers
Farhaan Hafeez, Xiaoying Hui, Marc Selner, et al.
European Journal of Dermatology : EJD
|
August 25, 2010
Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story"
Ana Gimenez-Arnau, Marcus Maurer, Jesús De La Cuadra, et al.
Molecular Pharmaceutics
|
October 4, 2024
Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes
Mohsen Ghaferi, Seyed Ebrahim Alavi, Khanh Phan, et al.
Journal of Applied Toxicology : JAT
|
September 29, 2016
Effects of soap-water wash on human epidermal penetration
Hanjiang Zhu, Eui-Chang Jung, Christina Phuong, et al.
Journal of Applied Toxicology : JAT
|
November 17, 2015
Effects of soap-water wash on human epidermal penetration
Hanjiang Zhu, Eui-Chang Jung, Christina Phuong, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews
|
July 26, 2021
Efficacy of water-based skin decontamination of occupational chemicals using <i>in vitro</i> human skin models: a systematic review
Chavy Chiang, Nadia Kashetsky, Aileen Feschuk, et al.
Cutaneous and Ocular Toxicology
|
July 27, 2011
Allergic contact dermatitis: effect of age
Hongbo Zhai, Susan R Meier-Davis, Brenda Cayme, et al.
Cutaneous and Ocular Toxicology
|
October 5, 2011
Irritant contact dermatitis: effect of age
Hongbo Zhai, Susan R Meier-Davis, Brenda Cayme, et al.
Cutaneous and Ocular Toxicology
|
March 29, 2013
Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?
Giovanni Brandi, Michela Venturi, Emi Dika, et al.
Cutaneous and Ocular Toxicology
|
May 4, 2013
Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
Annalisa Patrizi, Michela Venturi, Emi Dika, et al.
Page
of 13